Iterum Therapeutics plc announced that Mark Chin informed management that he would be resigning as a member of the Board of Directors of the company with effect from December 31, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.22 USD | +0.83% |
|
+8.93% | -38.07% |
06-21 | Sector Update: Health Care Stocks Gain in Late Afternoon | MT |
06-21 | Sector Update: Health Care | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.07% | 20.2M | |
+23.13% | 46.93B | |
+37.83% | 39.08B | |
-8.73% | 38.48B | |
+28.09% | 31.01B | |
-12.26% | 26.14B | |
+10.57% | 25.88B | |
+45.05% | 14.15B | |
+32.23% | 12.53B | |
-6.56% | 11.36B |
- Stock Market
- Equities
- ITRM Stock
- News Iterum Therapeutics plc
- Iterum Therapeutics plc Announces the Resignation of Mark Chin as Director, Effective December 31, 2023